Document is current
Any future updates will be listed below
-
Authors
Casasampere, Mireia
Carneros, Hector
Roda, Tania
Zuin, Alice https://orcid.org/0000-0003-1945-9623
Gallisà-Suñé, Núria https://orcid.org/0000-0003-2874-0345
González-Artero, Alba
Coll-Martínez, Bernat
Abad, José Luis
Alqahtani, Abdulateef
Casas, Josefina
Fernández-Nogueira, Patricia
Delgado, Antonio
Bujons, Jordi https://orcid.org/0000-0003-2944-2905
Fabriàs, Gemma https://orcid.org/0000-0001-7162-3772
Crosas, Bernat https://orcid.org/0000-0002-4303-2198
- License Information
-
More Information
Article History
Received: 2 July 2024
Accepted: 16 March 2026
First Online: 28 March 2026
Competing interests
: JC, JB, GF, BC, JLA, and AD are named as inventors on a patent application (PCT/EP2025/056573) claiming the use of the described 26S-UIDs for use for the treatment of cancer related to CERT1, filed by the Spanish National Research Council. The other authors declare no competing interests.
